Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Ophthalmologists warn that overexposure to sun's UV rays can cause temporary blindness

With the arrival of summer, when the sun's ultraviolet rays are strongest, ophthalmologists − medical doctors who specialize in the diagnosis, medical and surgical treatment of eye diseases and conditions − are warning the public that overexposure to these rays can burn the eyes' corneas and cause painful, temporary blindness.

4 Jun 2013

Ohr Pharmaceutical declares 1-for-3 reverse split of its outstanding common stock

Ohr Pharmaceutical, Inc. (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced a 1-for-3 reverse split of the Company's issued and outstanding common stock. The reverse stock split will be effective prior to the stock market opening on Monday, June 3, 2013.

3 Jun 2013

Perceptual learning may hold promise for improving visual functions in people with central vision loss

Perceptual learning techniques may provide a useful new approach to rehabilitation in patients with central vision loss-taking advantage of visual plasticity that persists even in old age, according to a special article in the June issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

28 May 2013

New study reveals another duet played by Notch and BMP signals

A small ensemble of musicians can produce an infinite number of melodies, harmonies and rhythms. So too, do a handful of workhorse signaling pathways that interact to construct multiple structures that comprise the vertebrate body.

15 May 2013

Fish oil supplements may not alter progression of age-related macular degeneration, say researchers

A large-scale National Eye Institute study has shown fish oil supplements containing omega-3 fatty acids do not alter the progression of age-related macular degeneration, says a national team of researchers including David M. Brown, M.D., an retina specialist at The Methodist Hospital who ran Houston's part of the study.

14 May 2013

New book proposes ways to help people see better with macular degeneration, low vision

Dr. Randolph C. Kinkade , a Connecticut optometrist and founding member of the International Academy of Low Vision Specialists, has written the Guide for Macular Degeneration Eyeglasses: Low Vision Treatment.

10 May 2013

New skin cancer drug successfully tested in humans

A new class of drug targeting skin cancer's genetic material has been successfully tested in humans for the first time, opening the way to new treatments for a range of conditions from skin cancers to eye diseases.

8 May 2013

ACT announces European phase I clinical trial for Stargardt's disease using retinal pigment epithelial cells

Advanced Cell Technology, Inc. a leader in the field of regenerative medicine, today announced treatment of the first patient in the third dosage cohort, and seventh patient overall, in its European Phase I clinical trial for Stargardt's macular dystrophy (SMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs).

26 Apr 2013

Acucela begins phase 2b/3 clinical trial of emixustat hydrochloride to treat GA associated with dry AMD

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for sight threatening eye diseases, today announced that a phase 2b/3 clinical trial investigating emixustat hydrochloride in subjects with geographic atrophy associated with dry age-related macular degeneration has been initiated.

25 Apr 2013

Ceregene announces top-line data from CERE-12 Phase 2b clinical study for Parkinson's disease

Ceregene, Inc. today announced the top-line data from its double-blind, randomized, controlled Phase 2b clinical study of CERE-120 (AAV-neurturin), a gene therapy product designed to deliver the neurotrophic factor neurturin, for Parkinson's disease.

20 Apr 2013

Implant improves vision for patients suffering from macular degeneration

Physicians at the Virginia Commonwealth University Medical Center have become the first in Virginia to successfully implant a telescope in a patient's eye to treat macular degeneration.

16 Apr 2013

Genes for blood vessel growth in retina are "switched on" by SRF protein

Normal functioning of the eye depends on a proper supply of blood to the retina. Light entering the eye passes through the cornea, the lens, and the vitreous body before reaching the retina, where it stimulates the nerves.

9 Apr 2013

Professor of neurology outlines case studies of hallucinations of musical notation

Professor of neurology, physician, and author Oliver Sacks M.D. has outlined case studies of hallucinations of musical notation, and commented on the neural basis of such hallucinations, in a new paper for the neurology journal Brain.

5 Apr 2013

Despite discovery of sight-saving drugs, AMD still causes severe vision loss in older Americans

Age-related macular degeneration continues to be the leading cause of visual impairment in the United States for people over age 65, according to a study recently published online in Ophthalmology, the journal of the American Academy of Ophthalmology.

4 Apr 2013

Study suggests drugs prescribed to lower cholesterol may be effective against macular degeneration

A new study raises the intriguing possibility that drugs prescribed to lower cholesterol may be effective against macular degeneration, a blinding eye disease. Researchers at Washington University School of Medicine in St. Louis have found that age-related macular degeneration, the leading cause of vision loss in Americans over 50, shares a common link with atherosclerosis.

3 Apr 2013

Targeting cholesterol metabolism in eye may prevent age-related macular degeneration, says study

Targeting cholesterol metabolism in the eye might help prevent a severe form of age-related macular degeneration (AMD), one of the most common causes of blindness in older Americans, according to indications in a study in mice, which was supported by the National Institutes of Health.

3 Apr 2013

Researchers identify link between immune response and blood clotting

Rice University researchers have found an unexpected link between a protein that triggers the formation of blood clots and other proteins that are essential for the body's immune system.

2 Apr 2013

AACR recognizes scientists whose contributions to cancer field have extraordinary impact

Five University of California, San Diego scientists and professors are among the first class of the Fellows of the American Association for Cancer Research Academy, created to recognize researchers whose scientific contributions have propelled significant innovation and progress against cancer.

29 Mar 2013

Phase II trial results of OHR/AVR118 in patients with cancer cachexia announced

Ohr Pharmaceutical, a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced the results of a Phase II trial to evaluate the effects of OHR/AVR118 in advanced cancer patients with cachexia. Cancer cachexia is the complex, multi-symptom syndrome seen in late-stage cancer patients, characterized by anorexia and unintended loss of appetite, progressive and continual weight loss, accompanied by generalized host tissue wasting, skeletal muscle atrophy, immune and metabolic dysfunction, and a greatly diminished quality of life.

21 Mar 2013

Research reveals method to produce retinal cells from regenerative human stem cells

Research led by a biology professor in the School of Science at Indiana University-Purdue University Indianapolis has uncovered a method to produce retinal cells from regenerative human stem cells without the use of animal products, proteins or other foreign substances, which historically have limited the application of stem cells to treat disease and other human developmental disorders.

20 Mar 2013

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Ophthalmologists warn that overexposure to sun's UV rays can cause temporary blindness

Ohr Pharmaceutical declares 1-for-3 reverse split of its outstanding common stock

Perceptual learning may hold promise for improving visual functions in people with central vision loss

New study reveals another duet played by Notch and BMP signals

Fish oil supplements may not alter progression of age-related macular degeneration, say researchers

New book proposes ways to help people see better with macular degeneration, low vision

New skin cancer drug successfully tested in humans

ACT announces European phase I clinical trial for Stargardt's disease using retinal pigment epithelial cells

Acucela begins phase 2b/3 clinical trial of emixustat hydrochloride to treat GA associated with dry AMD

Ceregene announces top-line data from CERE-12 Phase 2b clinical study for Parkinson's disease

Implant improves vision for patients suffering from macular degeneration

Genes for blood vessel growth in retina are "switched on" by SRF protein

Professor of neurology outlines case studies of hallucinations of musical notation

Despite discovery of sight-saving drugs, AMD still causes severe vision loss in older Americans

Study suggests drugs prescribed to lower cholesterol may be effective against macular degeneration

Targeting cholesterol metabolism in eye may prevent age-related macular degeneration, says study

Researchers identify link between immune response and blood clotting

AACR recognizes scientists whose contributions to cancer field have extraordinary impact

Phase II trial results of OHR/AVR118 in patients with cancer cachexia announced

Research reveals method to produce retinal cells from regenerative human stem cells

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in